enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
0.3633
+0.0180 (5.21%)
Nov 25, 2025, 4:00 PM EST - Market closed
enVVeno Medical Market Cap
enVVeno Medical has a market cap or net worth of $7.34 million as of November 26, 2025. Its market cap has decreased by -88.07% in one year.
Market Cap
7.34M
Enterprise Value
-22.82M
1-Year Change
-88.07%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since May 31, 2018, enVVeno Medical's market cap has decreased from $40.00M to $7.34M, a decrease of -81.64%. That is a compound annual growth rate of -20.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 6.98M | -86.82% |
| Dec 31, 2024 | 52.96M | -22.63% |
| Dec 29, 2023 | 68.45M | 41.69% |
| Dec 30, 2022 | 48.31M | -22.58% |
| Dec 31, 2021 | 62.40M | 222.87% |
| Dec 31, 2020 | 19.33M | 96.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.84B |
| Johnson & Johnson | 492.51B |
| AbbVie | 406.82B |
| UnitedHealth Group | 288.75B |
| AstraZeneca | 283.06B |
| Merck & Co. | 250.21B |
| Novartis AG | 243.93B |
| Abbott Laboratories | 223.34B |